Status
Conditions
Treatments
About
The aim of the DYNAMITE study is to investigate the (a) acute procedural and (b) 9-month follow-up performance of DynamX Drug-Eluting Coronary Bioadaptor System implantation in complex coronary lesions.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Presence of complex coronary lesions defined as follows:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
55 participants in 1 patient group
Loading...
Central trial contact
Antonio Colombo, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal